cerrar
Tagged with Europe

Fabian Gerber – Senior Relationship Manager Primary…
Fabian Gerber of SIX Swiss Exchange, Switzerland's principal stock exchange, outlines the importance of life sciences companies to the exchange,…

Josua Jordi – CEO & Co-Founder, EraCal Therapeutics
Josua Jordi of Swiss biotech EraCal explains the company’s technology platform, their work with zebrafish larvae to find a biologic mechanism to…

Luis Iglesias – President & Head of EMEA, Santen
Santen is a leading multinational company that specializes in ophthalmology. President and Head for Europe, Middle East and Africa (EMEA) Luis…

Spanish Pharma News: Market Growth; Esteve’s US Expansion; PTS…
The latest from Spanish pharma, including the acquisition of PTS by a private equity group for its nanoparticle drug delivery technologies; the…

Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI) by 38 percent and NASDAQ Biotech by 46 per cent between 2015 and 2020.…

Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and fallout of the EU/AstraZeneca…

Cyril Titeux – Senior VP Mid-sized Markets EMEA &…
Janssen’s Cyril Titeux highlights the commonalities and challenges within his 31-country portfolio, his hopes and expectations for the evolution of…

Top 10 Fastest Growing Private UK Pharma Companies 2021
The top 10 fastest-growing private pharma companies in the UK for 2021, compiled by corporate finance advisory firm Alantra. Featured companies…

MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich specialising in R&D, data management, and commercialisation,…

UK Pharma News: Fastest Growing Private Pharmacos; GSK Shake-Up;…
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma giant; CDMO Sterling’s latest…

Michael Altorfer – CEO, Swiss Biotech Association
Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses…

Switzerland: A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC) firm aiming to support founders…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here